查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439925

神經設備 - 全球市場考量、競爭格局、市場預測 (2030)

Neurology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2024-2030年期間，全球神經設備市場規模將以7.46%的複合年增長率成長。由於全球對神經設備的監管批准不斷增加等因素，該市場呈現樂觀的市場成長。此外，由於事故和工傷導致的頭部受傷的增加、人口老化的增加以及神經系統疾病盛行率的增加預計將增加世界各地對各種神經系統設備的需求。此外，日益關注提高最終用戶神經設備的安全性、可用性和易用性預計將在預測期內（2024-2030 年）推動神經設備市場收入的顯著增長。

神經裝置市場動態

阿茲海默症(AD)、亨丁頓舞蹈症(HD)、帕金森氏症(PD) 和多發性硬化症(MS) 等難以治療的神經系統疾病的盛行率不斷增加，導致人們加大了對其治療和管理的力度。需要發現安全有效的藥物分子。根據世界衛生組織（WHO）（2022）的數據，2020年全球約有5,500萬人患有失智症，每年都會發生數百萬例失智症病例。根據世界衛生組織（2022）的數據，2019 年全球約有 850 萬人受到帕金森氏症（PD）的影響，PD 導致 580 萬名殘疾調整生命年。

人口老化的增加是神經設備成長的另一個主要因素。根據世界衛生組織 (WHO) (2022) 的數據，到 2030 年，至少六分之一的人將超過 60 歲。根據同一數據，到2050年，60歲及以上的人口將約為21億人。隨著年齡的增長，更有可能患上各種神經系統疾病，例如癡呆症和中風。

因此，上述因素將共同推動 2024-2030 年預測期內的整體神經設備市場。

然而，與各種神經設備相關的高成本和風險可能會限制神經設備市場的成長。

在 COVID-19 大流行期間，由於為避免將感染傳播給醫院工作人員和公眾的風險而進行了封鎖，神經設備市場受到了負面影響。因此，隨著 COVID-19 在世界各地的傳播，醫院和診所的神經內科被關閉，神經外科也被暫停。此外，由於市場上供應鏈、原料和其他資源的缺乏，所有醫療器材的產量都在下降。然而，隨著 COVID-19 疫苗的開發、封鎖規定的放鬆以及經濟形勢的正常化，醫院、診所和實驗室的正常門診治療和診斷已不再可能。隨著醫療服務的恢復，需求產品在神經設備市場已經起飛。

神經設備市場細分分析

在神經設備市場的設備類型細分市場中，神經刺激治療細分市場預計將在 2023 年佔據重要的收入佔有率。這主要是由於與神經刺激設備相關的關鍵優勢。

例如，神經刺激裝置，例如脊髓刺激器，在治療神經性疼痛和脊髓損傷方面非常有效。

這些設備針對特定的深部皮質下、皮質、脊髓、顱骨和周圍神經結構來修改或調節神經元活動，有助於治療慢性疼痛、運動障礙、癲癇、帕金森氏症和無數其他疾病。它對神經系統疾病有治療作用疾病。

因此，考慮到對該產品類型不斷增長的需求，許多新產品正在市場上推出。例如，2022 年 8 月，Abbott的新型脊髓刺激 (SCS) 系統 Proclaim(TM) Plus 獲得美國食品藥物管理局 (FDA) 批准。

2022年7月，NEVRO CORP宣佈其用於治療與疼痛性糖尿病神經病變（PDN）相關的慢性疼痛的10kHz高頻脊髓刺激療法獲得美國FDA批准。

因此，由於與神經刺激設備相關的好處和應用，以及市場上產品不斷增加，預計該類別將在預測期內呈現可觀的成長，並為全球神經刺激設備市場的整體成長做出貢獻。

該報告提供了全球神經科設備市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章神經設備市場報告簡介

第二章神經設備市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章神經科設備市場主要因素分析

  • 神經設備市場的驅動因素
    • 神經系統疾病盛行率增加
    • 受傷人數增加
    • 微創手術需求增加
  • 神經科設備市場的限制與挑戰
    • 這些設備的成本很高
    • 與神經設備相關的風險
  • 神經設備市場的機會
    • 擴大新興市場的醫療基礎設施
    • 增加研發活動

第五章神經設備市場波特五力分析

第六章 COVID-19COVID-19對神經設備市場的影響分析

第七章 神經設備市場佈局

  • 按設備類型
    • 神經刺激設備
    • 神經外科設備
    • 腦脊髓液管理設備
    • 神經干預
    • 其他
  • 按用途
    • 診斷
    • 治療
  • 按最終用戶
    • 醫院
    • 專科診所
    • 門診手術中心
  • 區域
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第八章神經設備市場公司及產品概況

  • Abbott
  • B. Braun SE
  • Boston Scientific Corporation
  • Integra LifeSciences
  • LivaNova PLC
  • Medtronic
  • MagstimTMS
  • Penumbra, Inc
  • Stryker
  • MicroPort Scientific Corporation
  • Koninklijke Philips N.V.
  • Rapid Medical
  • Acandis GmbH
  • Cerus Endovascular Inc.
  • Helius Medical Technologies
  • Zimmer Biomet
  • Sense Neuro
  • Natus Medical Incorporated.
  • Braintale SAS
  • Avanos Medical, Inc.

第9章 KOL觀點

第10章項目方法

第 11 章關於 DelveInsight

第十二章 免責聲明與聯絡我們

Product Code: DIMDCL0606

Neurology Devices Market By Device Type (Neurostimulation Devices, Neurosurgery Devices, Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, And Others ], By Application (Diagnosis And Treatment), By End-User (Hospitals, Speciality Clinics, And Ambulatory Surgical Centers), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence and incidence of brain injury, dementia, alzheimer's diseases, and others, and the rising burden of geriatric population across the globe

The global neurology devices market is estimated to grow at a CAGR of 7.46% during the forecast period from 2024 to 2030. The neurology devices market is observing optimistic market growth due to factors such as the rise in the number of regulatory approvals for neurology devices across the globe. Further, the increasing cases of head injuries owing to accidents, workplace injuries, and others, and the rise in the geriatric population coupled with the increasing prevalence of neurological diseases are going to increase the demand for various neurological devices across the globe. Additionally, the growing focus on improving the safety, affordability, and usability of neurology devices for end users is further expected to result in appreciable revenue growth in the neurology devices market during the forecast period (2024-2030).

Neurology Devices Market Dynamics:

The increasing prevalence of hard-to-treat neurological diseases such as Alzheimer's disease (AD), Huntington's disease (HD), Parkinson's disease (PD), and multiple sclerosis (MS) among others will require the discovery of safer and more efficient drug molecules for their treatment and management. As per the World Health Organization (WHO) 2022, worldwide around 55 million people were suffering from dementia in 2020 and every year millions of cases of dementia take place. According to WHO 2022, worldwide around 8.5 million people had Parkinson's disease (PD) in 2019 and as per the same source, PD lead to 5.8 million disability-adjusted life years.

The increasing geriatric population is another major factor in the growth of neurology devices. As per the World Health Organization 2022, it is expected that by 2030, out of 6 at least 1 person will have his/her age 60 years or above. As per the same source, by 2050, the number of people aged 60 years or above will be around 2.1 billion. With increasing age, the tendency to suffer from various neurological diseases such as dementia, stroke, and others increases tremendously.

Therefore, the factors stated above collectively will drive the overall neurology devices market during the forecast period from 2024-2030.

However, the high cost and risk associated with various neurology devices may act as a restraint in the neurology devices market growth.

The Neurology Devices Market was negatively impacted during the period of COVID- 19 pandemic owing to the lockdown impositions to avoid the risk of the spread of the disease among hospital personnel and the general public. This led to the closure of neurology departments in hospitals and clinics leading to the suspension of neurological procedures due to the huge spread of COVID-19 infection across the globe. Further, shortage of supply chains, raw materials, and other resources in the market, leading to the decreased manufacturing of all medical devices. However, the vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has initiated the process of resumption of regular healthcare services such as regular out-patients visits for treatments and diagnosis in hospitals, clinics, and laboratories, thereby bringing the demand for products on track in the neurology devices market.

Neurology Devices Market Segment Analysis:

Neurology Devices Market By Product Type (Neurostimulation Devices, Neurosurgery Devices, Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, and Others], By Application (Diagnosis and Treatment), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment of the Neurology Devices market, the neurostimulation segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the key benefits related to neurostimulation devices.

For instance, neurostimulation devices such as spinal cord stimulators are highly effective in treating neuropathic pain and spinal injuries.

These devices target specific deep subcortical, cortical, spinal, cranial, and peripheral nerve structures to modify or modulate neuronal activity and therefore provide therapeutic effects for countless neurological diseases including chronic pain, movement disorders, epilepsy, and Parkinson's disease among others.

Therefore, considering the growing demand for this product type, numerous new products are being launched in the market. For example, In August 2022, Abbott received U.S. Food and Drug Administration (FDA) approval for its new Proclaim(TM) Plus spinal cord stimulation (SCS) system.

In July 2022, NEVRO CORP announced that it has received US FDA clearance for its 10 kHz high-frequency spinal cord stimulation therapy for the treatment of chronic pain associated with painful diabetic neuropathy (PDN).

Therefore, owing to the advantages and applications associated with neurostimulation devices along with the increasing product launches in the market, the category is expected to witness considerable growth eventually contributing to the overall growth of the global neurology devices market during the forecast period.

North America is expected to dominate the overall Neurology Devices Market:

Among all the regions, North America is expected to dominate the global neurology devices in the year 2023 and is expected to do the same during the forecast period from 2024-2030. This can be ascribed to the rising prevalence of head injuries and neurological diseases including Parkinson's disease, Alzheimer's disease, and others; the rise in the geriatric population, rising product launches and approvals in the region, the presence of key market players in the region, and others will increase the demand of neurology devices in the given forecast period.

For instance, according to the latest data available from the American Society for Biochemistry and Molecular Biology data published in the year 2023, in the United States, a brain injury occurs every nine seconds, resulting in more than 3.5 million incidents each year. Moreover, as per the above-referenced source and statistics, about 2.8 million people suffer from traumatic brain injury (TBI) each year in the United States from which 2,80,000 result in hospitalizations. Therefore, rising cases of head injuries such as Traumatic Brain Injury (TBI) will increase the demand for neurology devices.

Additionally, as per the latest information provided by Parkinson's Foundation, every year approximately 60,000 people in America are diagnosed with PD. Also, the data provided by GLOBOCAN 2020 says that around 24,538 cancer cases of the brain and central nervous system were recorded in the US in 2020.

Also, the increasing prevalence of Alzheimer's disease in the United States will drive the market for diagnostic devices. As per the data provided by the Alzheimer Association (2023), more than 6 million Americans are living with Alzheimer's. By 2050, this number is projected to rise to nearly 13 million. The increasing prevalence of Alzheimer's disease in the United States will increase the demand for its diagnostics devices, ultimately leading to increased overall market growth.

Therefore, the interplay of the above-mentioned factors would provide a conducive environment for the growth of the North America neurology devices market.

Neurology Devices Market Key Players:

Some of the key market players operating in the neurology devices market include Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences, LivaNova plc, Medtronic, Magstim TMS, Penumbra, Inc, Stryker, MicroPort Scientific Corporation, Koninklijke Philips N.V., Rapid Medical, Acandis GmbH, Helius Medical Technologies, Cerus Endovascular Inc., Zimmer Biomet, Sense Neuro, Natus Medical Incorporated, Braintale SAS, Avanos Medical Inc., and others.

Recent Developmental Activities in the Neurology Devices Market:

In May 2022, the US Food and Drug Administration today permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer's disease.

In November 2022, Insightec received US FDA approval for a new device intended for treating patients with advanced Parkinson's disease named Exablate Neuro.

In April 2020, Brainquant, a quantitative brain measurement device, launched by Braintale SAS received CE mark approval for managing patients in a coma following brain injury.

Key Takeaways from the Neurology Devices Market Report Study

  • Market size analysis for current neurology devices market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Neurology Devices market.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global neurology devices market.
  • Various opportunities available for the other competitor in the Neurology Devices Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current Neurology Devices Market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Neurology Devices Market growth in the coming future?

Target Audience who can be benefited from this Neurology Devices Market Report Study

  • Neurology Devices products providers
  • Research organizations and consulting companies
  • Neurology Devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Neurology Devices
  • Various end users who want to know more about the neurology devices market and the latest technological developments in the neurology devices market.

Frequently Asked Questions for the Neurology Devices Market:

1. What is a neurology device?

Neurological devices are medical devices that are meant for the diagnosis and treatment of several neurological diseases and include neurostimulation devices, neurosurgery devices, and others.

2. What is the global market for Neurology Devices?

The global neurology devices market is estimated to grow at a CAGR of 7.46% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Neurology Devices market?

The neurology devices market is witnessing positive market growth owing to the increasing prevalence and incidence of brain injury, dementia, Alzheimer's diseases, and others; the rising burden of the geriatric population across the globe, and others will create an exigency in the Neurology Devices market.

4. Who are the key players operating in the global Neurology Devices market?

Some of the key market players operating in the neurology devices market include Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences, LivaNova plc, Medtronic, Magstim TMS, Penumbra, Inc, Stryker, MicroPort Scientific Corporation, Koninklijke Philips N.V., Rapid Medical, Acandis GmbH, Helius Medical Technologies, Cerus Endovascular Inc., Zimmer Biomet, Sense Neuro, Natus Medical Incorporated, Braintale SAS, Avanos Medical Inc., and others.

5. Which region has the highest share in the Neurology Devices market?

Among all the regions, North America is estimated to amass a significant revenue share in the global neurology devices market. This can be ascribed to the rising prevalence of head injuries, Parkinson's disease, Alzheimer's disease, and others; the rise in the geriatric population and the presence of key market players in the region are factors that act as a supportive factors for the North America Neurology Devices Market growth.

Table of Contents

1.Neurology Devices Market Report Introduction

2.Neurology Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Neurology Devices Market Key Factors Analysis

  • 4.1. Neurology Devices Market Drivers
    • 4.1.1. Increasing prevalence of neurological diseases
    • 4.1.2. Rising number of traumatic injuries
    • 4.1.3. Increasing demand for minimally invasive surgeries
  • 4.2. Neurology Devices Market Restraints and Challenges
    • 4.2.1. High Cost of these devices
    • 4.2.2. The risk associated with neurology devices
  • 4.3. Neurology Devices Market Opportunities
    • 4.3.1. Expansion of healthcare infrastructure across emerging markets
    • 4.3.2. Increasing research and development activities

5. Neurology Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Neurology DevicesMarket

7. Neurology Devices Market Layout

  • 7.1. By Device Type
    • 7.1.1. Neurostimulation Devices
    • 7.1.2. Neurosurgery Devices
    • 7.1.3. Cerebrospinal Fluid Management Devices
    • 7.1.4. Interventional Neurology
    • 7.1.5. Others
  • 7.2. By Application
    • 7.2.1. Diagnosis
    • 7.2.2. Treatment
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Specialty Clinics
    • 7.2.3. Ambulatory Surgical Centers
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Neurology Devices Market in USD million (2021-2030)
      • 7.3.1.2. Canada Neurology Devices Market in USD million (2021-2030)
      • 7.3.1.3. Mexico Neurology Devices Market in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.2. Germany Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.4. Italy Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.5. Spain Neurology Devices Market in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Neurology Devices Market in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.2. Japan Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.3. India Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.4. Australia Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.5. South Korea Neurology Devices Market in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia Pacific Neurology Devices Market in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Neurology Devices Market in USD million (2021-2030)
      • 7.3.4.2. Africa Neurology Devices Market in USD million (2021-2030)
      • 7.3.4.3. South America Neurology Devices Market in USD million (2021-2030)

8. Neurology Devices Market Company and Product Profiles

  • 8.1. Abbott
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. B. Braun SE
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Boston Scientific Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Integra LifeSciences
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. LivaNova PLC
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Medtronic
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. MagstimTMS
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Penumbra, Inc
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Stryker
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. MicroPort Scientific Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Koninklijke Philips N.V.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Rapid Medical
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Acandis GmbH
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Cerus Endovascular Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Helius Medical Technologies
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Zimmer Biomet
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Sense Neuro
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Natus Medical Incorporated.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Braintale SAS
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Avanos Medical, Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Neurology Devices Market
  • Table 3: Neurology Devices Market Analysis in Global (2021-2030)
  • Table 4: Neurology Devices Market Analysis in Global by Device Type (2021-2030)
  • Table 5: Neurology Devices Market Analysis in Global by Application (2021-2030)
  • Table 6: Neurology Devices Market Analysis in Global by End-user (2021-2030)
  • Table 7: Neurology Devices Market Analysis in Global by Geography (2021-2030)
  • Table 8: Neurology Devices Market Analysis in North America (2021-2030)
  • Table 9: Neurology Devices Market Analysis in North America by Country (2021-2030)
  • Table 10: Neurology Devices Market Analysis in the US (2021-2030)
  • Table 11: Neurology Devices Market Analysis in Canada (2021-2030)
  • Table 12: Neurology Devices Market Analysis in Mexico (2021-2030)
  • Table 13: Neurology Devices Market Analysis in Europe (2021-2030)
  • Table 14: Neurology Devices Market Analysis in Europe by Country (2021-2030)
  • Table 15: Neurology Devices Market Analysis in France (2021-2030)
  • Table 16: Neurology Devices Market Analysis in Germany (2021-2030)
  • Table 17: Neurology Devices Market Analysis in the UK (2021-2030)
  • Table 18: Neurology Devices Market Analysis in Italy (2021-2030)
  • Table 19: Neurology Devices Market Analysis in Spain (2021-2030)
  • Table 20: Neurology Devices Market Analysis in the Rest of Europe (2021-2030)
  • Table 21: Neurology Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 22: Neurology Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 23: Neurology Devices Market Analysis in China (2021-2030)
  • Table 24: Neurology Devices Market Analysis in Japan (2021-2030)
  • Table 25: Neurology Devices Market Analysis in India (2021-2030)
  • Table 26: Neurology Devices Market Analysis in Australia (2021-2030)
  • Table 27: Neurology Devices Market Analysis in South Korea (2021-2030)
  • Table 28: Neurology Devices Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Table 29: Neurology Devices Market Analysis in the Rest of the World (2021-2030)
  • Table 30: Neurology Devices Market Analysis in the Rest of the World by Region (2021-2030)
  • Table 31: Neurology Devices Market Analysis in the Middle East (2021-2030)
  • Table 32: Neurology Devices Market Analysis in Africa (2021-2030)
  • Table 33: Neurology Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Neurology Devices Market
  • Figure 3: Neurology Devices Market Analysis in Global (2021-2030)
  • Figure 4: Neurology Devices Market Analysis in Global by Device Type (2021-2030)
  • Figure 5: Neurology Devices Market Analysis in Global by Application (2021-2030)
  • Figure 6: Neurology Devices Market Analysis in Global by End-user (2021-2030)
  • Figure 7: Neurology Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 8: Neurology Devices Market Analysis in North America (2021-2030)
  • Figure 9: Neurology Devices Market Analysis in North America by Country (2021-2030)
  • Figure 10: Neurology Devices Market Analysis in the US (2021-2030)
  • Figure 11: Neurology Devices Market Analysis in Canada (2021-2030)
  • Figure 12: Neurology Devices Market Analysis in Mexico (2021-2030)
  • Figure 13: Neurology Devices Market Analysis in Europe (2021-2030)
  • Figure 14: Neurology Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 15: Neurology Devices Market Analysis in France (2021-2030)
  • Figure 16: Neurology Devices Market Analysis in Germany (2021-2030)
  • Figure 17: Neurology Devices Market Analysis in the UK (2021-2030)
  • Figure 18: Neurology Devices Market Analysis in Italy (2021-2030)
  • Figure 19: Neurology Devices Market Analysis in Spain (2021-2030)
  • Figure 20: Neurology Devices Market Analysis in the Rest of Europe (2021-2030)
  • Figure 21: Neurology Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 22: Neurology Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 23: Neurology Devices Market Analysis in China (2021-2030)
  • Figure 24: Neurology Devices Market Analysis in Japan (2021-2030)
  • Figure 25: Neurology Devices Market Analysis in India (2021-2030)
  • Figure 26: Neurology Devices Market Analysis in Australia (2021-2030)
  • Figure 27: Neurology Devices Market Analysis in South Korea (2021-2030)
  • Figure 28: Neurology Devices Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Figure 29: Neurology Devices Market Analysis in the Rest of the World (2021-2030)
  • Figure 30: Neurology Devices Market Analysis in the Rest of the World by Region (2021-2030)
  • Figure 31: Neurology Devices Market Analysis in the Middle East (2021-2030)
  • Figure 32: Neurology Devices Market Analysis in Africa (2021-2030)
  • Figure 33: Neurology Devices Market Analysis in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Market Opportunities
  • Figure 37: PORTER's Five Force Analysis